1. 2018
  2. Protective effect of genetic deletion of pannexinl in experimental mouse models of acute and chronic liver disease

    Willebrords, J., Maes, M., Alves Pereira, I. V., da Silva, T. C., Govoni, V. M., Veras Lopes, V., Crespo Yanguas, S., Shestopalov, V. I., Nogueira, M. S., de Castro, I. A., Farhood, A., Mannaerts, I., van Grunsven, L. A., Akakpo, J., Lebofsky, M., Jaeschke, H., Cogliati, B. & Vinken, M., Mar 2018, In : Biochimica et Biophysica Acta - Molecular Basis of Disease. 1864, 3, p. 819-830 12 p.

    Research output: Contribution to journalArticle

  3. Functional cardiotoxicity assessment of cosmetic compounds using human-induced pluripotent stem cell-derived cardiomyocytes

    Chaudhari, U., Nemade, H., Sureshkumar, P., Vinken, M., Ates, G., Rogiers, V., Hescheler, J., Hengstler, J. & Sachinidis, A., 20 Jan 2018, In : Archives of Toxicology. 92, 1, p. 371-381 11 p.

    Research output: Contribution to journalArticle

  4. Development and testing of a repeated dose toxicity ontology model for chemical risk assessment purposes: liver effects as a case study

    Gustafson, E., Klaric, M., Kienhuis, A., Van De Water, B., Cronin, M., Kramer, N., Kroese, D., Daston, G., Yang, C., Desprez, B. & Vinken, M., 2018.

    Research output: Unpublished contribution to conferencePoster

  5. 2017
  6. Adverse Outcome Pathways as Versatile Tools in In Vitro and In Silico Toxicology—Part II

    Vinken, M. (Guest ed.), 12 Dec 2017, In : Applied In Vitro Toxicology. 3, 4, p. 283-332

    Research output: Contribution to journalSpecial issue

  7. An update on adverse outcome pathways leading to liver injury

    Gijbels, E. & Vinken, M., 12 Dec 2017, In : Applied In Vitro Toxicology. 3, 4, p. 283-285 3 p.

    Research output: Contribution to journalArticle

  8. Adverse outcome pathways: a concise introduction for toxicologists

    Vinken, M., Knapen, D., Vergauwen, L., Hengstler, J., Angrish, M. & Whelan, M., 21 Nov 2017, In : Archives of Toxicology. 91, 11, p. 3697-3707 11 p.

    Research output: Contribution to journalArticle

  9. Adverse outcome pathways: opportunities, limitations and open questions

    Leist, M., Ghallab, A., Graepel, R., Marchan, R., Hassan, R., Hougaard Bennekou, S., Limonciel, A., Jennings, P., Vinken, M., Schildknecht, S., Waldmann, T., Danen, E., van Ravenzwaay, B., Kamp, H., Gardner, I., Godoy, P., Bois, F., Albert, B., Reif, R., Terron, A. & 12 others, Bal-Price, A., Oesch, F., Drasdo, D., Höhme, S., Michael, S., Hartung, T., Braunbeck, T., Beltman, J., Vrieling, H., Sanz, F., Van De Water, B. & Hengstler, J., 21 Nov 2017, In : Archives of Toxicology. 91, 11, p. 3477-3505 29 p.

    Research output: Contribution to journalArticle

  10. Inhibitors of connexin and pannexin channels as potential therapeutics

    Willebrords, J., Maes, M., Crespo Yanguas, S. & Vinken, M., 4 Nov 2017, In : Pharmacology & Therapeutics. 180, p. 144-160 17 p.

    Research output: Contribution to journalArticle

  11. Adverse Outcome Pathways as Versatile Tools in In Vitro and In Silico Toxicology—Part I

    Vinken, M. (Guest ed.), 15 Sep 2017, In : Applied In Vitro Toxicology. 3, 3, p. 211-281 70 p.

    Research output: Contribution to journalSpecial issue

  12. Editorial

    Vinken, M., 15 Sep 2017, In : Applied In Vitro Toxicology. 3, 3, p. 211-212

    Research output: Contribution to journalEditorial

Previous 1 2 3 4 5 6 7 8 ...27 Next

ID: 91145